Stockscreener 앱 받기
226.22
1.27%
-2.91
시장 영업 전:
226.05
-0.17
-0.08%
Abbvie Inc 주식(ABBV)의 최신 뉴스
AbbVie (ABBV) Stock Falls Amid Market Uptick: What Investors Need to Know - Yahoo Finance
AbbVie's Bretisilocin Hit With Enveric IP Claim - Yahoo
OSE Immunotherapeutics publie ses résultats financiers du 1er semestre 2025 - GlobeNewswire Inc.
Can AbbVie Inc. stock outperform in 2025 bull marketFed Meeting & Daily Oversold Bounce Ideas - newser.com
Enveric Biosciences (ENVB) Pursues Legal Action Against AbbVie - GuruFocus
Enveric Biosciences Hires IP Powerhouse to Defend Its U.S. Patent with Claims Relevant to Bretisiloc - PharmiWeb.com
AbbVie breaks ground on new API manufacturing plant in North Chicago - Chicago Construction News
AbbVie could face patent battle over depression asset gained in Gilgamesh deal - Seeking Alpha
Enveric contests patent review petition related to AbbVie acquisition - Investing.com
AbbVie (ABBV) Pursues Acquisition Amid Patent Dispute Over Breti - GuruFocus
Top Medical Aesthetics Companies in 2025 - vocal.media
AbbVie (ABBV): Assessing Valuation After Strong 28% Year-to-Date Share Price Jump - Yahoo Finance
Can Rinvoq and Skyrizi Sales Drive Another Strong Quarter for AbbVie? - The Globe and Mail
Amazon, AbbVie, Datadog And A Financial Stock: CNBC's 'Final Trades' - Benzinga
Does AbbVie's Latest AI Partnership Signal More Room for Its 2025 Rally? - Yahoo Finance
Abbvie gets USFDA approval for updated indication statement for Rinvoq for Inflammatory Bowel Disease - Medical Dialogues
Pharma companies announce direct-to-consumer sales and price cuts in US - Reuters
FDA Expands AbbVie's Rinvoq (ABBV) Indication for Colitis and Cr - GuruFocus
FDA Expands AbbVie's (ABBV) RINVOQ Approval for Ulcerative Colit - GuruFocus
AbbVie Stock Rises After FDA Approves Changed Recommendations For Use Of Popular Rinvoq Drug - Stocktwits
FDA approves updated indication for AbbVie’s RINVOQ in IBD treatment - Investing.com
Use after 1 approved systemic therapy — AbbVie gets FDA approval to update RINVOQ IBD label allowing pre‑TNF use - Stock Titan
2 Dividend Stocks to Double Up on Right Now - The Globe and Mail
Abbvie to Present New Data At Esmo 2025 Reinforcing Leadership in Advancing Targeted Therapies for Solid Tumors - MarketScreener
AbbVie to Present New Data at ESMO 2025 Reinforcing Leadership in Advancing Targeted Therapies for Solid Tumors - Investing News Network
AbbVie (ABBV) to Present New Antibody-Drug Conjugate Data at ESM - GuruFocus
Atria Wealth Solutions Inc. Reduces Position in AbbVie Inc. $ABBV - MarketBeat
AbbVie Inc. $ABBV Shares Sold by Envestnet Portfolio Solutions Inc. - MarketBeat
Concord Asset Management LLC VA Purchases 1,691 Shares of AbbVie Inc. $ABBV - MarketBeat
AbbVie Inc. $ABBV Shares Sold by Vest Financial LLC - MarketBeat
Griffin Asset Management Inc. Lowers Stake in AbbVie Inc. $ABBV - MarketBeat
M.E. Allison & CO. Inc. Has $466,000 Stake in AbbVie Inc. $ABBV - MarketBeat
AbbVie Inc. $ABBV Shares Acquired by MOKAN Wealth Management Inc. - MarketBeat
AbbVie Inc. $ABBV is Welch Group LLC's 9th Largest Position - MarketBeat
Almanack Investment Partners LLC. Boosts Stock Holdings in AbbVie Inc. $ABBV - MarketBeat
Criteria Caixa S.A.U. Sells 47,822 Shares of AbbVie Inc. $ABBV - MarketBeat
Cwm LLC Has $60.03 Million Holdings in AbbVie Inc. $ABBV - MarketBeat
AbbVie Inc. $ABBV is Advocate Group LLC's 4th Largest Position - MarketBeat
Vanguard Personalized Indexing Management LLC Acquires 37,680 Shares of AbbVie Inc. $ABBV - MarketBeat
AbbVie Inc. $ABBV Shares Bought by OFI Invest Asset Management - MarketBeat
Nationale Nederlanden Powszechne Towarzystwo Emerytalne S.A. Buys Shares of 23,920 AbbVie Inc. $ABBV - MarketBeat
Sather Financial Group Inc Purchases New Position in AbbVie Inc. $ABBV - MarketBeat
2,500 Shares in AbbVie Inc. $ABBV Bought by Summa Corp. - MarketBeat
Johnson Investment Counsel Inc. Lowers Holdings in AbbVie Inc. $ABBV - MarketBeat
Why Analysts See AbbVie’s Story Shifting After Strategic Wins and Growth Upgrades - Yahoo Finance
AbbVie Inc. $ABBV Holdings Lowered by Natural Investments LLC - MarketBeat
Fifth Third Wealth Advisors LLC Sells 4,542 Shares of AbbVie Inc. $ABBV - MarketBeat
One Degree Advisors Inc Buys New Position in AbbVie Inc. $ABBV - MarketBeat
AbbVie Inc. $ABBV Shares Acquired by Conning Inc. - MarketBeat
Drucker Wealth 3.0 LLC Purchases 2,817 Shares of AbbVie Inc. $ABBV - MarketBeat
AbbVie Inc. $ABBV Shares Acquired by Eastern Bank - MarketBeat
Forefront Analytics LLC Invests $1.28 Million in AbbVie Inc. $ABBV - MarketBeat
Lmcg Investments LLC Decreases Stock Position in AbbVie Inc. $ABBV - MarketBeat
Strong Tower Advisory Services Raises Stock Position in AbbVie Inc. $ABBV - MarketBeat
AbbVie (NYSE:ABBV) Lowered to Hold Rating by Wall Street Zen - MarketBeat
AbbVie And Amgen's Blueprint To Digitalize Biomanufacturing - Bioprocess Online
Goldman Sachs Adjusts AbbVie Price Target to $218 From $217, Maintains Neutral Rating - MarketScreener
Why AbbVie Inc. is moving todayJuly 2025 Price Swings & Consistent Growth Equity Picks - newser.com
Piper Sandler raises Abbvie stock price target to $284 on strong portfolio - Investing.com Canada
Piper Sandler Raises Price Target for AbbVie (ABBV) to $284, Mai - GuruFocus
Is Trending Stock AbbVie Inc. (ABBV) a Buy Now? - Yahoo Finance
Blue Trust Inc. Trims Position in AbbVie Inc. $ABBV - MarketBeat
Cyndeo Wealth Partners LLC Grows Stake in AbbVie Inc. $ABBV - MarketBeat
Commerzbank Aktiengesellschaft FI Has $24.07 Million Stock Holdings in AbbVie Inc. $ABBV - MarketBeat
Cardano Risk Management B.V. Grows Holdings in AbbVie Inc. $ABBV - MarketBeat
McKinley Carter Wealth Services Inc. Raises Stake in AbbVie Inc. $ABBV - MarketBeat
Callan Family Office LLC Boosts Holdings in AbbVie Inc. $ABBV - MarketBeat
AbbVie Inc. $ABBV Shares Bought by IFP Advisors Inc - MarketBeat
Horizon Bancorp Inc. IN Has $538,000 Holdings in AbbVie Inc. $ABBV - MarketBeat
Ramirez Asset Management Inc. Acquires 8,100 Shares of AbbVie Inc. $ABBV - MarketBeat
0.17%
0.22%
자본화:
|
볼륨(24시간):